Items tagged with Guidelines
WHO launches Target Regimen Profiles for TB treatment (post with simple image)
The new profiles seek to guide the drug/regimen development process, enabling important drug and regimen features to respond to the needs of end-users, care providers and policymakers.
Desk guide for diagnosis and management of TB in children (post with simple image)
The Union has published the third edition of Desk Guide for Diagnosis and Management of TB in Children.
WHO maintains existing recommendations for the use of bedaquiline (post with simple image)
The conditional recommendation will be maintained until a new systematic review of evidence is warranted or the results of the phase III clinical trial of bedaquiline become available.
Guidelines for treatment of drug-susceptible tuberculosis and patient care, 2017 update (post with simple image)
The World Health Organization releases updated guidelines for the treatment of drug-susceptible TB and patient care.
WHO advises on the use of multidisease testing devices for TB, HIV and hepatitis (post with simple image)
A new document provides a strategic overview of key implementation considerations for diagnostic integration using testing devices for TB, HIV and viral hepatitis.
New WHO report provides blueprint for delivering people-centred care for TB (post with simple image)
WHO/Europe releases a blueprint for a people-centred model of TB care that shifts care closer to people and communities.
Good Participatory Practice Guidelines for TB Vaccine Research (post with simple image)
Aeras releases a document providing systematic guidance on how to effectively engage stakeholders throughout the entire life cycle of TB vaccine research.
Compendium of WHO guidelines and associated standards (post with simple image)
Compendium of WHO guidelines and associated standards: ensuring optimum delivery of the cascade of care for patients with tuberculosis
WHO position statement on the use of delamanid for MDR-TB (post with simple image)
The World Health Organization issues a position statement on the use of delamanid for multidrug-resistant TB following an expedited review of phase III clinical trial results.
Advocates call on WHO to consolidate and revise its guidance regarding the treatment for MDR-TB (post with simple image)
TB CAB issues a position statement on the use of bedaquiline as part of the preferred regimen for MDR-TB.
Page 5 of 7 · Total posts: 0←First 4 5 6 Last→